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Identification of novel nesprin-1 binding partners 
and cytoplasmic matrin-3 in processing bodies
ABSTRACT Nesprins are highly conserved spectrin repeat–containing scaffold proteins pre-
dominantly known to function at the nuclear envelope (NE). However, nesprin isoforms are 
emerging with localizations and scaffolding functions at sites away from the NE, suggesting 
their functions are more diverse than originally thought. In this study, we combined nesprin-1 
coimmunoprecipitations with mass spectrometry to identify novel nesprin-1 binding partners 
for isoforms that localize to subcellular compartments beyond the NE. We show that one of 
these interactors, matrin-3 (matr3), localizes to mRNA processing bodies (PBs), where we 
have previously shown a nesprin-1 isoform to localize. Furthermore, we show that Matr3 is 
part of PB mRNP complexes, is a regulator of miRNA-mediated gene silencing, and possibly 
shuttles to stress granules in stressed cells. More importantly, we identify a new C-terminally 
truncated Matr3 isoform that is likely to be involved in these functions and PB localization. 
This study highlights several novel nesprin-1 binding partners and a new function and local-
ization for Matr3 in cytoplasmic RNA granules.
INTRODUCTION
Nesprins are a novel spectrin-repeat (SR) family of cellular scaffolds 
and linkers, predominantly known to localize to the nuclear enve-
lope (NE; Zhang et al., 2001; Mellad et al., 2011). To date, four 
nesprin genes have been identified, and their full-length proteins 
localize to the outer nuclear membrane and provide connections to 
cytoskeletal filaments. Full-length nesprin-1 and nesprin-2 bind F-
actin directly via their N-terminal calponin homology domains 
(Zhang et al., 2002). The SRs of nesprin-3 and nesprin-4 interact with 
plectin and Kif5b in a manner that establishes intermediate filament 
and microtubule connections, respectively (Wilhelmsen et al., 2005; 
Roux et al., 2009). NE nesprins are one of the major components of 
the linker of the nucleoskeleton and cytoskeleton (LINC) complex 
and form connections with inner NE transmembrane SUN domain 
proteins in the perinuclear space. In turn, the SUN domain proteins 
interact with the nuclear lamina underlying the inner nuclear mem-
brane to complete the LINC complex (Crisp et al., 2006). This 
double membrane–spanning complex maintains nuclear integrity, 
mediates nuclear anchorage and positioning, and plays a definitive 
role in mechanosensing and cell migration (Razafsky et al., 2014; 
Chang et al., 2015).
The emergence of KASH-less nesprin isoforms, generated by 
alternative transcription, has provided evidence for nesprin func-
tionality beyond the NE (Rajgor and Shanahan, 2013). Indeed, all 
the KASH-less nesprin isoforms examined thus far have localized, 
often in a cell-specific manner, to an array of different cellular com-
partments, including focal adhesions, the nucleolus, the Golgi, and 
promyelocytic leukemia bodies, and diffusively in the cytosol and 
nucleus (Kobayashi et al., 2006; Warren et al., 2010; Rajgor et al., 
2012). Recently we reported the presence of p50Nesp1 in mRNA pro-
cessing bodies (P-bodies, or PBs). p50Nesp1 is a short variant of ne-
sprin-1 composed entirely of SRs that facilitates PB anchorage to 
microtubules and plays a role in PB dynamic properties such as lo-
calized movement (Rajgor et al., 2014). Data from this and other 
studies suggest that miniature nesprin-1 isoforms composed of SRs 
otherwise located in the central rod region of nesprin-1 giant can 
localize in the nucleus and cytosol (Warren et al., 2010; Rajgor et al., 
2012, 2014).
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RESULTS
Identification of novel nesprin-1 binding partners
To further characterize the ability of nesprin-1 to function as an intra-
cellular scaffold, we set out to identify novel binding partners for 
KASH-less nesprin-1 isoforms. Coimmunoprecipitations (co-IPs) 
with two previously characterized nesprin-1 polyclonal antibodies 
(pAbN4 and pAbN5) were performed on U2OS whole-cell lysates 
(Figure 1A). The epitopes for these antibodies are located within SR 
49 of the nesprin-1 giant and are separated by several amino acid 
residues. In U2OS cells, both antibodies only detect PB and nuclear 
nesprin-1 variants, as previously described (Rajgor et al., 2014).
pAbN4, pAbN5, and control immunoglobulin G (IgG) immune 
complexes from U2OS cells were separated by SDS–PAGE, and sil-
ver-stained bands present in both pAbN4 and pAbN5 lanes, but not 
the negative control IgG lane, were identified by mass spectrometry 
(Figure 1B). Only proteins detected by both antibodies were consid-
ered as potential novel interactors. These included nuclear compo-
nents involved in RNA processing such as Matr3, PTB-associated 
splicing factor (PSF), DDx5, and hnRNP A2/B1. Cytoplasmic proteins 
were also identified (HSP90, 40S ribosomal protein SA, creatine ki-
nase, cytoskeletal actin) as well as Importin-β, suggesting that these 
KASH-less nesprin-1 variants may function 
as intracellular nuclear, cytoplasmic, and 
nuclear envelope scaffolds consistent with 
their localizations (Rajgor et al., 2014).
Interestingly, no nesprin-1 was detected 
by mass spectrometry, which may be due to 
poor detection of nesprin-1 peptides by 
mass spectrometry or because the bands 
corresponding to nesprin-1 were not suffi-
ciently excised or digested from the silver-
stained gels. To confirm nesprin-1 was being 
immunoprecipitated by pAbN4 and pAbN5, 
we performed Western blotting with a previ-
ously described nesprin-1 monoclonal anti-
body (4C11) to show nesprin-1 enrichment 
within pAbN4 and pAbN5 immune com-
plexes (Holt et al., 2016). Indeed, nesprin-1 
isoforms p50Nesp1, p144Nesp1, and nesprin-1β 
were detected in pAbN4 and pAbN5 IPs. 
Further Western blotting was performed to 
confirm the presence of Matr3, PSF, DDx5, 
and Importin-β (Figure 1C). Although matr3, 
PSF, and DDx5 coimmunoprecipitated with 
nesprin-1, Importin-β was also present within 
the control IgG immune complexes and 
therefore not considered as a potential ne-
sprin-1 binding protein.
To confirm the interaction between ne-
sprin-1 with matr3, PSF, and DDx5, we 
performed glutathione S-transferase (GST) 
pull-down experiments using previously de-
scribed GST-nesprin-1 constructs (Figure 1D). 
GST-SR1, GST-SR2, GST-SR3, and GST-SR4 
represent SRs 48–51 of nesprin-1 giant and 
are also the four SRs that comprise the 
p50Nesp1 isoform that localizes to PBs. These 
constructs were selected because they are 
present in close proximity to the nesprin-1 
pAbN4 and pAbN5 epitopes. Interestingly, 
matr3 and DDx5 associated with SR1 and 
SR2, respectively, which are the same SRs 
In this study, we identified potential nesprin-1 interacting part-
ners for KASH-less nesprin-1 variants to further characterize the 
function of nesprins as intracellular scaffolds and linkers. Mass spec-
trometry identified a host of proteins associated with nesprin-1 
involved in RNA-processing events, including matrin-3 (Matr3). 
Matr3 is a well-established nuclear matrix protein identified two de-
cades ago (Nakayasu and Berezney, 1991). However, its function is 
only beginning to emerge through the identification of novel bind-
ing partners that suggest matr3 functions in a number of key cellular 
processes, including chromatin remodeling, transcription, RNA 
splicing, DNA replication and repair, and apoptosis (Zhang and 
Carmichael, 2001; Zeitz et al., 2009; Salton et al., 2010; Coelho 
et al., 2015).
Here we report a role for a new potential matr3 isoform in 
miRNA-mediated translational repression and show for the first time 
its localization in PBs. By identifying matr3 PB-localizing and PB-
binding domains, we suggest cytoplasmic functions for matr3 and 
speculate that neuronal and muscular degenerative diseases caused 
by mutations within the matr3 gene could hamper posttranscrip-
tional processes associated with cytoplasmic matr3 RNA-processing 
events (Senderek et al., 2009; Johnson et al., 2014).
FIGURE 1: Identification of novel nesprin-1 binding partners. (A) Schematic illustrating the 
location of pAbN4 and pAbN5 relative to the nesprin-1 giant, nesprin-1β, and smaller KASH-less 
nesprin-1 isoforms. (B) SDS–PAGE and silver-stained gel of pAbN4 and pAbN5 co-IPs. Table 
summarizes interacting partners identified by mass spectrometry that were present in both 
nesprin-1 immune complexes but not the IgG control. (C) Validation of mass spectrometry 
binding partners by co-IPs and Western blotting (N = 4). (D) GST pull downs using SRs located in 
the central rod region of nesprin-1 at bait (N = 3).
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blotting, with which we observed a ∼75.6% knockdown of matr3, 
∼59.6% knockdown of DDx5, and ∼64.9% knockdown of p54 
(Figure 2A). Endogenous Let-7a was unable to attenuate luciferase 
silencing in DDx5-depleted cells; however, matr3 knockdown en-
hanced luciferase activity comparable to Rck/p54 depletion, sug-
gesting Matr3 is required for miRNA-mediated gene silencing 
(Figure 2B). When the Let-7a binding sites of the luciferase re-
porter were mutated so they could no longer associate with en-
dogenous Let-7a, no change in luciferase activity was observed 
under any of the knockdown conditions (Figure 2C). These data 
suggest matr3 induces translational repression in a miRNA-
mediated manner.
Additionally, we monitored the ability of exogenous CXCR4 
miRNA to silence a luciferase reporter containing 6×CXCR4 miRNA 
binding sites (Doench et al., 2003). As with the Let-7a reporter, no 
change in luciferase activity was seen in DDx5-depleted cells, while 
matr3- and p54-depleted cells had significantly enhanced luciferase 
expression (Figure 2D). Together these experiments suggest Matr3 
is a novel component of the miRISC complex required for miRNA-
mediated gene silencing.
Matr3 localizes to RNA PBs
Matr3 is a 95 kDa nuclear matrix protein containing two RNA-
recognition motifs (RRMs) flanked by two zinc finger (ZnF) domains 
(Figure 3A). The functions of these domains remain unclear; how-
ever, matr3 has multifunctional properties in many cellular processes 
(Zhang and Carmichael, 2001; Zeitz et al., 2009; Salton et al., 2010; 
Coelho et al., 2015). Therefore we examined the cellular localization 
of matr3 using antibodies targeting the N-terminal (M3N) or C-
terminal (M3C) ends of the protein in U2OS cells (Figure 3B). Both 
M3N and M3C antibodies stained the 
nuclear matrix; however, M3N additionally 
detected cytoplasmic foci that colocalized 
with the PB marker Hedls (Figure 3B). This 
suggests that matr3 is present in PBs, which 
is consistent with its miRISC function.
Matr3 interacts with PB proteins
To identify whether PB protein complexes 
were associated with matr3, we probed 
M3N and M3C immune complexes for 
Ago2, p54, and Dcp1a (Figure 4A). M3C im-
mune complexes did not contain any of the 
PB proteins, while all 3 PB components were 
present in M3N immune complexes, of 
which Ago2 association was RNA depen-
dent. Both M3N and M3C contained PSF, a 
nuclear matr3 binding partner, and served 
as a positive control for matr3 isolated 
protein complexes (Figure 4A; Zhang and 
Carmichael, 2001).
New matr3 isoform localizes to PBs
Next we investigated whether nuclear and 
cytosolic matr3 represents a common pool 
of the protein by probing U2OS cytosolic 
and nuclear extracts with antibodies to 
M3N, lamin B1, and α-tubulin (Figure 4B). 
The presence of lamin B1 only in the nuclear 
extract and α-tubulin only in the cytosolic 
pool suggested pure fractions of the two 
compartments. Western blotting with M3N 
that we have previously shown to bind miRNA-mediated gene si-
lencing (miRISC) regulators Argonaute-2 (Ago2) and p54/DDx6. PSF 
did not associate with any of the SRs used in this experiment, sug-
gesting that it likely interacts with another of the many SRs of ne-
sprin-1 (Figure 1D). Together these experiments identify novel ne-
sprin-1 binding partners and potential new functions for nesprin-1.
Matr3 is required for miRISC function
SR48 and SR49 (SR1 and SR2 domains in Figure 1D) of nesprin-1, 
which Matr3 and DDx5 associate with, have previously been shown 
to be required for miRISC function (Rajgor et al., 2014). Further-
more, matr3 and DDx5 have also previously been identified in Ar-
gonaute protein complexes (Hock et al., 2007; Rajgor et al., 2014). 
Together these experiments suggest matr3 and DDx5 may be part 
of the miRISC complex required for miRNA-mediated gene silenc-
ing. We therefore decided to perform the Let-7a miRISC reporter 
assay to determine whether these two proteins are required for 
miRNA-mediated gene silencing. The psi-CHECK2-let-7a 3× lucif-
erase vector contains 3×Let-7a miRNA-binding sites, and lucifer-
ase expression is translationally repressed when transfected into 
cells expressing endogenous Let-7a and functional miRISC com-
plexes (Lytle et al., 2007; Johnston et al., 2010). Knockdown of 
core silencing proteins involved in miRISC pathways, for example, 
Rck/p54, GW182, or p50Nesp1, reduces miRISC activity (Chu and 
Rana, 2006; Rajgor et al., 2014). To determine whether matr3 or 
DDx5 is also required for this process, we performed the Let-7a 
miRISC assay in U2OS cells depleted of either DDx5 or matr3 with 
small interfering RNAs (siRNAs). Rck/p54 knockdown was also per-
formed and served as a positive control for these assays. Success-
ful knockdown of these proteins was determined by Western 
FIGURE 2: Matr3 is required for miRISC function. (A) Western blotting demonstrating 
efficient knockdown of matrin3, DDx5, and p54 using their respective siRNAs (N = 4). 
(B) Cells depleted of Matr3 have attenuated miRISC function of a Let-7a reporter assay. 
p54 knockdown cells served as a positive control (N = 4). (C) Endogenous Let-7a does not 
suppress activity of the reporter under any knockdown condition when the Let-7a binding 
sites are mutated (N = 4). (C, D) Cells depleted of Matr3 have attenuated miRISC function of 
CXCR4 reporter assay (N = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.001; one-way ANOVA, 
Dunnett’s post hoc test.
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Matr3 ZnF1 and RRM1 are required for PB and SG 
localization
PB detection with the N-terminal antibody and siRNA knockdown of 
the ∼50 kDa band with si-M3N suggest that PB matr3 is likely to re-
tain its N-terminal domains, assuming no unusual alternative splic-
ing of matr3 occurs. Therefore, to determine which domains of 
matr3 were required for PB localization, we created Flag-tagged 
matr3 C-terminal truncation constructs by introducing stop codons 
after every major domain of matr3 (Figure 5A). Full-length Flag-
matr3, Flag-798, and Flag-567 all showed nuclear matrix localization 
in U2OS cells. However, removal of the second RRM in Flag-469 in-
duced cytoplasmic foci formation, with some transfected cells also 
displaying weak nuclear localization. Subsequent truncation of 
RRM1 in Flag-322 resulted in loss of cytoplasmic foci (Figure 5A).
The phenotype of cytoplasmic foci induced by Flag-469 ap-
peared to look like a mixture of PBs and stress granules (SGs) at first 
glance. As matr3 has previously been detected in SGs by mass 
spectroscopy and in matr3 overexpression studies (Gallego-Iradi 
et al., 2015; Jain et al., 2016), we costained Flag-469–transfected 
cells with the endogenous PB marker p54 and SG marker PABP-1 
(Figure 5B). Interestingly, under basal conditions, Flag-469 induced 
SG formation, even though it colocalized predominantly with p54 
PBs. However, when cells were heat shocked at 42°C for 45 min, 
Flag-469 foci translocated to SGs (Figure 5B). These data suggest 
that matr3 plays a role in SG induction from PBs and is capable of 
translocating to SGs during stress.
Next GST pull downs were performed with Matr3 GST-469, GST-
322, and GST-RRM1 to determine which portion of the protein 
contained the relevant binding sites for PB protein complexes 
(Figure 5C). Matr3 GST-469 pulled down endogenous Ago2 and 
p54 from U2OS cell extracts, while GST-322 or GST-RRM1 were un-
able to do so, suggesting that the PB-binding region requires both 
the ZnF1 and RRM1 domains (Figure 5C).
As Flag-469 translocated from PBs to SGs under thermal shock, 
we examined whether Flag-469 interactions with PB proteins were 
disrupted after heat shock. Flag-469 co-IPs had less Ago2 and p54 
after stress compared with control cells, suggesting Flag-469 
binds to fewer PB proteins after heat shock (Figure 5D). Together 
these experiments highlight a signicant portion of the matr3 pro-
tein that is required for PB and SG localization and interaction with 
PB proteins.
We then examined whether endogenous PB matr3 was capable 
of moving from PBs to stress granules. After heat shock, cells were 
costained with matr3 and Hedls or PABP-1 (Figure 6). Interestingly, 
we observed a reduction in nuclear matr3 after heat shock. There 
was also a significant reduction in matr3 foci colocalizing with Hedls 
PBs, matching the data seen with Flag-469 and PBs following heat 
shock (Figure 5B). Although matr3 foci did have greater Pearson’s 
colocalization coefficient with PABP-1 after stress, only very weak co-
localization was observed compared with the strong colocalization 
coefficient observed between Flag-469 and PABP-1 after stress 
(Figures 6 and 5B). Thus there are slight discrepancies between the 
behavior of endogenous matr3 and ectopic Flag-469, which are 
likely due to differing sequences of Flag-469 and endogenous matr3.
Next we attempted to identify the origin of the truncated Matr3 
PB variant by performing 5′ and 3′ rapid amplification of cDNA ends 
(RACE) on a HeLa cell cDNA library. However, no new sequences 
were amplified (unpublished data). Additionally, publicly available 
databases were screened for clones that could represent this iso-
form. However, this also failed to identify novel variants, suggesting 
that further investigation of matr3 sequences is required to identify 
this variant.
detected the 95 kDa matr3 protein in the nucleus, while a smaller 
∼50 kDa band was present in the cytosolic fraction (Figure 4B). Prob-
ing for M3C detected only the 95 kDa band in the nuclear fraction 
(unpublished data). These data indicate that two populations of 
Matr3 are present: a 95 kDa protein in the nucleus and a smaller 
∼50 kDa protein in the cytoplasm.
We performed co-IPs to identify which proteins were associated 
with the two different matr3 species (Figure 4C). Ago2, Rck/p54, 
and Dcp1a, but not PSF, immune complexes were enriched with the 
smaller 50 kDa matr3 variant, while PSF coimmunoprecipitated with 
the larger 95 kDa nuclear matr3 protein. Western blotting of these 
co-IPs for the three PB proteins and PSF showed no PSF to be pres-
ent in PB complexes or visa versa (i.e., no PB components in PSF 
immune complexes; Figure 4C).
To identify whether the 50 kDa band was a novel isoform, 
splice variant, cleavage product, or a nonspecific protein recog-
nized by the M3N antibody, we used siRNAs created against the 
N-terminal and C-terminal (si-M3N and si-M3C, respectively) 
open reading frame of matr3. Western blotting demonstrated si-
M3N was able to knock down both the 95 and 50 kDa bands, 
while si-M3C only knocked down the larger 95 kDa band 
(Figure 4D). Both siRNAs were able to knock down nuclear matr3 
levels, as measured by fluorescence intensity within the nucleus 
(Figure 4E). Previously, U2OS cells have been established to con-
tain several PBs under basal conditions (Rajgor et al., 2014). 
Therefore, to determine PB knockdown with the siRNAs, we ex-
amined 400 U2OS cells and counted the percentage of cells that 
had between 0 and 4 PBs. si-M3N–transfected cells had a large 
population of cells containing fewer than 4 PBs (35 ±7.70%, 
n = 400), while si-M3C–transfected cells had PBs comparable to 
the control siRNA (si-M3C 75 ±7.62%, and si-control 79.25 
±4.57%, n = 400) (Figure 4E). Together these experiments sug-
gest a novel N-terminal matr3 variant exists in PBs that is differ-
ent from the nuclear matr3 identified to date.
FIGURE 3: Matr3 localizes to PBs. (A) Schematic representation 
illustrating the structure of matr3 and the location of M3N and 
M3C antibodies. (B) M3C detects the nuclear matrix in U2OS cells. 
M3N detects the nuclear matrix and cytoplasmic foci that 
colocalize with PB markers Hedls (N = 100–300 over four 
experimental repeats).
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be required for miRISC function. Although 
DDx5-depleted cells did not change Let-7a 
or CXCR4 miRSC activity, matr3 knockdown 
significantly attenuated miRISC function. 
The role matr3 plays in miRISC function has 
yet to be determined. Matr3 has previously 
been shown to bind small RNA, suggesting 
that it may be able to bind and sequester 
miRNAs from binding to mRNA targets 
(Salton et al., 2011). However, as matr3’s in-
teraction with Ago2 appears to be RNA de-
pendent, it is likely to have a more direct 
role with the RISC complex.
As an antibody targeting the C-terminal 
end of Matr3 was unable to detect matr3 
localization in PBs or coimmunoprecipitate 
with PB proteins, either a novel matr3 iso-
form or a cleavage product must reside 
within PBs. Indeed, by comparing nuclear 
and cytoplasmic fractions, we identified an 
∼50 kDa cytosolic matr3 variant, and using 
co-IPs, we showed this variant interacts with 
PB proteins. Because matr3-containing PBs 
were depleted along with the 50 kDa 
Western band using siRNAs targeting the 
N-terminal region of the protein, but not the 
C-terminal region, at least two variants of 
matr3 exist, one that localizes to the nuclear 
matrix and another that localizes to PBs. As 
the C-terminal siRNA was unable to knock-
down the 50 kDa Western band or PBs, the 
possibility of matr3 localizing to PBs as a 
result of a cleavage product of the larger 
nuclear protein is unlikely.
To identify the major domains required 
for matr3 PB localization, we created vari-
ous C-terminal truncation constructs. 
Matr3-469, which terminates after the first 
RRM, encodes a 52 kDa construct that we 
show to localize within PBs. The degree of 
homology that exists between this con-
struct and the actual ∼50 kDa matr3 isoform 
expressed in cells has yet to be determined. Interestingly, PB local-
ization through truncation constructs suggests that RRM1 is neces-
sary for localization, as its removal abolished cytoplasmic foci. Fur-
thermore, the PB protein-binding sites on matr3 are likely to be 
located on both RRM1 and ZnF1, as the individual domains do not 
associate with PB proteins. Identifying which mRNA or miRNA tran-
scripts bind with RRM1, along with any other protein-interacting 
partners that associate with the N-terminal portion of the protein, 
may help determine the role of matr3 in PBs.
The cytoplasmic foci formed by Flag-469 appeared to be a mix-
ture of PBs and SGs at first glance. However, staining for endoge-
nous PBs and SGs showed ectopic matr3-469 to predominantly 
localize in PBs, even though it was able to induce SG formation. 
These data indicate matr3 is important for SG formation from lo-
calizing to PBs, even though the mechanism of how it does this 
requires further work. Heat shock resulted in a stronger localization 
of matr3-469 in SGs, indicating it is also an SG protein, which is 
consistent with previous mass spectrometry data of SGs and over-
expression studies showing matr3 in SGs (Gallego-Iradi et al., 
2015; Jain et al., 2016). Furthermore, matr3 interactions with Ago2 
DISCUSSION
Nesprins are a diverse family of intracellular scaffolds and linkers 
required for maintaining cellular organization and architecture 
through the generation of multiple isoforms. Here we identified 
several new nesprin-1 binding partners that provide further evi-
dence that nesprin-1 is a versatile intracellular scaffold. Nesprin-1 
scaffolding has already been shown to have an important role in PB 
function, and in this study, we identify matr3 as a new binding part-
ner and define a previously unrecognized function for a well-studied 
nuclear protein in PB function.
Matr3 as a novel miRISC regulator, PB, and SG protein
We identified matr3 as both a nesprin-1 binding partner and as a 
novel candidate for miRISC function, as demonstrated using the Let-
7a and CXCR4 miRISC reporter constructs. Using an antibody raised 
against the N-terminus of matr3, we detected PB localization, which 
is consistent with the PB localization of nesprin-1 and its ability to 
interact with other PB proteins (Hock et al., 2007; Rajgor et al., 
2014). Matr3 and DDx5 associated with the nesprin-1 SRs, which 
have previously been shown to interact with Ago2 and p54 and to 
FIGURE 4: Unique matr3 is present within PBs. (A) Co-IPs with M3N and M3C show that only 
M3N immune complexes contain PB proteins. PSF served as a positive control (N = 4). (B) M3N 
detects two Western bands in U2OS whole-cell lysates. Subcellular fractions show the larger 
∼95 kDa band is present in the nuclear fraction, and the smaller ∼50 kDa band is present in the 
cytosol. Lamin B1 and α-tubulin were used to measure purity of nuclear and cytoplasmic 
fractions respectively (N = 4). (C) PB proteins coimmunoprecipitate with the smaller matr3 
variant, while PSF co-IPs with the larger form (N = 4). (D) si-M3N knocks down both M3N bands 
detected by Western blotting, while M3C only knocks down the larger molecular weight band 
(N = 5). (E) si-M3N knocks down cytoplasmic foci and nuclear matr3 staining. si-M3C does not 
affect PB but does eliminate nuclear staining. Cytoplasmic foci knockdown was determined by 
cells having <4 foci (N = 400 over four experimental repeats). Nuclear matr3 levels were 
measured by nuclear matr3 fluorescence integrated density (N = 100 over four experiments). 
*, p < 0.05; ****, p < 0.0001; one-way ANOVA, Dunnett’s post hoc test.
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of stress are applied (e.g. oxidative stress by arsenite) is worth 
exploring.
Using 3′ RACE we attempted to identify a novel 3′ mRNA end but 
were unsuccessful, possibly due to several limitations associated with 
this approach, which include difficulty in amplifying rare or potentially 
long transcripts. Alternate matr3 variants were also not detected on 
exploration of publicly available databases, making the elucidation of 
the origin of this 50 kDa variant a focus of future studies.
The localization of our matr3 constructs did provide additional in-
teresting findings about matr3. The nuclear localization signal (NLS) of 
matr3 has previously been shown to be located between residues 
596 and 602, which makes the nuclear localization of Flag-567 inter-
esting. Furthermore, a small population of Flag-469–transfected cells 
and p54 were disrupted after heat shock, suggesting PB functions 
may be hampered after stress. Whether Flag-469 is able to trans-
locate bound RNA species with it from PBs to SGs warrants further 
investigation. When we examined whether endogenous matr3 
displayed similar effects after heat shock, we did see a reduction 
of matr3 with PBs and only a weak colocalization with SGs. The 
discrepancies between matr3-469 and endogenous matr3 are 
likely to be due to differences in sequences between the two 
forms. Interestingly, we did observe a significant reduction in en-
dogenous nuclear matr3 levels after heat shock. Whether heat 
shock induces nuclear matr3 degradation or cytosolic transloca-
tion warrants further investigation. Also, whether a similar distribu-
tion is seen by Flag-469 and endogenous matr3 after other forms 
FIGURE 5: Matr3 ZnF1 and RBD1 are required for PB localization. (A) Flag-tagged C-terminal truncation constructs were 
created and transfected into U2OS cells. The table indicates which constructs had cytoplasmic and nuclear localizations 
(N = 30–50 over three experimental repeats). Flag-469 did have weak nuclear staining in a small population of transfected 
cells (13.33% of cells). (B) Flag-469 foci formed colocalize with PB marker p54 and induce SG formation, as indicated by 
PABP-1 staining. After heat shock (42°C, 45 min), Flag-469 moves from PBs to SGs. Colocalization of Flag-469 with p54 
PBs and PABP-1 SGs before and after SGs were quantified using Pearson’s colocalization coefficient (N = 15 over three 
experimental repeats). (C) GST-469 pulls down Ago2 and p54 from U2OS cell extract (N = 3). (D) Flag-469 has reduced 
interactions with Ago2 and p54 after heat shock. *, p < 0.05; **, p < 0.01; ****, p < 0.0001; Student’s t test.
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larly important in the central nervous system and muscle, where ne-
sprin (Emery-Dreifuss muscular dystrophy and autosomal-recessive 
cerebellar ataxia]) and matr3 (ALS) mutations have been shown to 
induce disease (Zhang et al., 2007; Johnson et al., 2014).
We also identified other nesprin-1 binding partners involved in a 
variety of cellular activities, including transcription (DDx5, PSF), 
alternative splicing (PSF, DDx5, hnRNP A2/B1, Matr3), and DNA 
replication/damage repair (PCNA, Matr3) in this study (Emili et al., 
2002; Fuller-Pace and Ali, 2008; Chen and Manley, 2009; Coelho 
et al., 2015). These findings illustrate the potential multifunctional 
nature of nesprin-1, wherein different isoforms generated through 
alternative transcription are likely to be involved in distinct biologi-
cal roles. No nesprin-1 was detected by mass spectrometry in our 
screen, which initially suggests that these may not be novel ne-
sprin-1 binding partners. However, we were able to show by West-
ern blotting that nesprin-1 was indeed present within pAbN4 and 
pAbN5 immune complexes. There are several reasons for the ab-
sence of nesprin-1 as seen by mass spectrometry. One possibility is 
that the bands corresponding to nesprin-1 were not sufficiently ex-
cised or digested from the silver-stained gels. Another more likely 
scenario is that the binding partners associate with more than one 
SR within nesprin-1 or that multiple nesprin-1 isoforms have the 
same binding partners. As the central rod domain of nesprin-1 is 
present in a large number of isoforms, and as many SRs share a high 
homology, either case is possible and would result in a greater 
enrichment of binding partners relative to nesprin-1 proteins. Fur-
thermore, we were able to map matr3 and DDx5 to specific SRs of 
nesprin-1 using GST pull downs, which strongly suggests that our 
screen did identify novel nesprin-1 binding partners. Identifying 
which proteins partner with the various nesprin-1 isoforms and the 
subcellular compartment in which these complexes localize will pro-
vide further insights into the importance of nesprin-1 variants as in-
tracellular scaffolds and possible clues to how mutations in nesprin-1 
may affect diverse signaling pathways in disease.
MATERIALS AND METHODS
Plasmids
Matr3 C-terminal truncations mutants were created by introducing 
termination codons into pCI-Flag-Matrin3DNA3.1, which was kindly 
provided by Christopher Smith (University of Cambridge), using the 
QuikChange II site-directed mutagenesis kit (Agilent, Santa Clara, 
CA). Primers used for creating the truncations were as follows: Flag-
798 (forward: 5′GACTATGTGATACCTAATAAAGGGTTTTACTGT
AAG CTG3′; reverse: 5′CAGCTTACAGTAAAACCCTTTATTAGG-
TATCACATAGTC3′), Flag-567 (forward: 5′GAGATGTGTGAAGG-
TTGACTAGTCTGAGAAATATAAAAAACTG3′; reverse: 5′CAGTTT-
TTTAT ATTTCTCAGACTAGTCAACCTTCACACATCTC3′), Flag-469 
(forward: 5′GCCAGTGAGAGTTCATTAATCCCAGAAGTATAAAA-
GA3′; reverse: 5′ TCTTTTATACTTCTGGGATTAATGAACTCTCACT-
GGC3′), Flag-322 (forward: 5′CGTCGATGCCAGCTTCTTTAAG-
AAATCTA CCCAGAATGG3′; reverse: 5′CCATTCTGGGTAGATTT-
CTTAAAG AAGCTGGCATCGACG3′). The psi-CHECK2-let-7 ×3 
and psi-CHECK2-let-7 3× mut vectors were kindly provided by G. 
Hutvagner (University of Dundee, Scotland, UK; Johnston et al., 
2010). pRL-TK CXCR4 6× vector was kindly provided by P. Sharp 
(MIT; Doench et al., 2003) via Addgene.
Tissue culture
U2OS cells were passaged when reaching ∼70% confluency and 
maintained in DMEM complete (Sigma, St. Louis, MO) supple-
mented with 10 U/ml penicillin, 10 mg/ml streptomycin, 10 mg/ml 
glutamine, and 10% fetal bovine serum. When appropriate, cells 
had weak nuclear localization, whereas Flag-322 was entirely cyto-
plasmic. These experiments suggest that there are at least two addi-
tional NLSs located within matr3; one between residues 470 and 567 
and a weak NLS between residues 333 and 469.
Matr3 mutations have been identified in amyotrophic lateral scle-
rosis (ALS), and these mutations also map to the N-terminal region of 
matr3 that localizes to PBs and SGs. Although nuclear matr3 functions 
such as transcription and splicing could be disrupted as a result of 
ALS-causing mutations, there is a possibility that specific functions of 
PB matr3, such as miRISC function or SG-assembly properties, are 
also hampered. This is further supported by other RNA granule pro-
teins, such as TDP-43 and FUS, also being mutated in ALS (Li et al., 
2013). Therefore further understanding of the role of matr3 in PB biol-
ogy may provide useful insight into understanding the onset of ALS.
New novel functions for Nesprin-1
Recently matr3 has been shown to interact with the C-terminal tail 
of lamin A/C, and this interaction is important in maintaining a cor-
rect interface between the lamina and nuclear matrix (Depreux 
et al., 2015). Smaller KASH domain–containing isoforms of nesprin-1 
also reside at the inner nuclear membrane and bind to lamin A/C. As 
nesprin-1 SRs share a high degree of homology, it is possible that 
SRs other than SR48 (SR1 in Figure 1D) bind matr3. Thus it is likely 
that nesprin variants present within the LINC complex also form a 
scaffold with nuclear matr3, further suggesting that nuclear envel-
opathies due to nesprin and lamin mutations may also exhibit im-
paired connections with matr3. It is also plausible that many of the 
matr3 functions identified, including alternative splicing, DNA dam-
age response, chromatin organization, and retention of hyperedited 
RNA, could be regulated by mechanical signals via the nesprins and 
the LINC complex (Ma et al., 1999; Zhang and Carmichael, 2001; 
Salton et al., 2010, 2011; Coelho et al., 2015). This may be particu-
FIGURE 6: After heat shock, endogenous matr3 does not colocalize 
with SGs; endogenous matr3 foci have reduced colocalization with 
Hedls PBs; and Matr3 foci have enhanced colocalization with PABP-1 
after heat shock, even though the degree of colocalization remains 
weak. Furthermore, nuclear matr3 levels were reduced after heat 
shock. Colocalizations quantified using Pearson’s colocalization 
coefficient (N = 15 over three experimental repeats). ****, p < 0.0001; 
Student’s t test.
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centrifuge to pellet nuclei. The supernatant containing the cytoplas-
mic fraction was transferred to a fresh Eppendorf. The pelleted 
nuclei were resuspended in an appropriate volume of RIPA buffer 
(150 mM KCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 
and protease inhibitor cocktail), vortexed, incubated on ice for 
10 min, and centrifuged at 13,050 × g for 10 min in a 4°C centrifuge. 
The supernatant was collected as the nuclear fraction, and 10–20 μg 
of protein per fraction was analyzed by Western blotting.
Western blotting
Cell extracts were resolved on a 10% SDS–PAGE gel and transferred 
to polyvinylidene fluoride membrane (Millipore, San Diego, CA) us-
ing a semidry apparatus. The membranes were blotted with the anti-
bodies indicated in each figure, and bands were visualized using the 
ECL Western blotting substrate (Thermo Fisher Scientific, Waltham, 
MA). Membranes were incubated with the following primary anti-
bodies: anti-Rck/p54 (ab54611; Abcam, Cambridge, United King-
dom), anti-Ago2 (ab57113; Abcam), anti-Dcp1a (ab57654; Abcam), 
anti–β-actin (A2228; Sigma), anti-Matr3C (ab84422; Abcam), anti-
Matr3N (ab51081; Abcam), PSF (sc-101137; Santa Cruz, Santa Cruz, 
CA), DDx5 (ab21696; Abcam), Importin-β (ab2811; Abcam) mouse 
anti–α-tubulin (T5168; Sigma-Aldrich), rabbit-LaminB1 (sc-20682; 
Santa Cruz). Secondary antibodies conjugated to horseradish peroxi-
dase (GE Healthcare) were used at 1:10,000 dilutions and developed 
using ECL reagent and X-ray film. Densitometry measurements were 
performed using ImageJ.
Let-7 miRISC luciferase assay
Twelve thousand U2OS cells were plated into each well of a 24-well 
plate and cultured under standard growth conditions overnight. The 
following day, three wells per experimental condition were cotrans-
fected with 1 μl Matr3, DDx5, Rck/p54, or scrambled siRNA oligos (all 
at 20-μM stock solutions) and 1 μg of psi-CHECK2-let-7 ×3 or psi-
CHECK2-let-7 ×3 m using Hiperfect transfection reagent (Qiagen). 
siMatr3 and si-DDx5 si-p54 sequences used were 5′GUCAUUCCAG-
CAGUCAUCUUU3′ and 5′AAGAGGUGGAAACAUACAGAA3′, re-
spectively. Si-p54 was a Smart pool obtained from Dharmacon 
(L-006371-00-000). Luciferase readings were taken 72 h after trans-
fection using the Dual-Luciferase Reporter assay (Promega, Madison, 
WI). Renilla luciferase activity was normalized to firefly luciferase ac-
tivity to control for transfection efficiency (both transcribed off the 
psi-CHECK2 plasmids).
CXCR4 miRISC luciferase assay
Twelve thousand U2OS cells were plated into each well of a 24-well 
plate and cultured under standard growth conditions overnight. The 
following day, three wells per experimental condition were trans-
fected with Hiperfect siRNA-plasmid complexes containing 1 μg 
pRL-TK CXCR4 6× Renilla luciferase plasmids, 50 ng pGL3.4 firefly 
luciferase plasmid, 1 μl CXCR4 siRNA oligo (20 μM stock), and 1 μl 
of siRNA oligo (20 μM stock) targeting proteins to be knocked 
down. Luciferase readings were taken 72 h after transfection using 
the Dual-Luciferase Reporter assay (Promega). Renilla luciferase ac-
tivity was normalized to firefly luciferase activity to control for trans-
fection efficiency.
siRNA-mediated gene silencing
Sixty thousand U2OS cells were plated into each well of a six-well 
plate and cultured under standard growth conditions overnight. The 
following day, cells were transfected with 1 μl siM3N, siM3C or 
scrambled siRNA oligos (all at 20-μM stock solutions) using Hiperfect 
transfection reagent (Qiagen, Hilden, Germany). siM3N and siM3C 
were treated with sodium arsenite (0.5 mM), nocodazole (10 μg/ml), 
or cycloheximide (10 μg/ml) or in fresh culture media for 1 h.
Co-IPs
Cells were washed with phosphate-buffered saline (PBS), and 
extracts were prepared by scraping cells in ice-cold co-IP buffer 
(10 mM Tris, pH 7.4, 150 mM KCl, 1 mM ethylenediaminetetraace-
tic acid [EDTA], 1% Triton, and protease inhibitor cocktail). For 
identifying novel nesprin-1 binding partners using mass spectrom-
etry, 250 mM KCl was used to increase stringency. Lysed cells were 
centrifuged at 13,050 × g for 20 min at 4°C and were precleared 
with protein A– or protein G–Sepharose beads (Sigma) for 1 h at 
4°C with rotation. Protein complexes were obtained by incubating 
2 μg of relevant antibody with 200 μg of cell lysate overnight at 
4°C with gentle rotation. Immune complexes were purified using 
Sepharose beads, washed three times with co-IP buffer, and boiled 
in loading buffer, and then the entire co-IP was analyzed by West-
ern blotting or silver staining.
The co-IPs for the RNase treatment were performed under iden-
tical conditions. However, washed beads were resuspended into co-
IP buffer and divided into two equal volumes. RNase mixture (10 μg/
ml; DNase free; Roche, Basel, Switzerland) was added to one, and 
both were incubated at room temperature (RT) for 20 min. After two 
washes in cold co-IP buffer, proteins were eluted in loading buffer.
GST pull down
GST and GST fusion proteins were induced from 100 ml of bacterial 
culture for 2 h using 0.2 mM isopropyl β-d-1-thiogalactopyranoside 
at 30°C. Ten to twenty microliters of culture was used for purification 
(the rest was pelleted and frozen) according to the GE Healthcare 
protocol using glutathione–Sepharose 4B beads (GE Healthcare, 
Little Chalfont, United Kingdom). Pull downs were performed from 
U2OS whole-cell lysates prepared as described above. Four hun-
dred micrograms of protein lysates was incubated with 30 μl beads 
overnight at 4°C with rotation. Bound proteins were eluted into pro-
tein loading buffer, and the entire pull down was analyzed by West-
ern blotting.
Mass spectrometry
Bands from silver-stained gels were excised and cut into small 
pieces of ∼2 mm using a sterile scalpel. In-gel digestion was per-
formed with trypsin on a robotic digestion system (Investigator 
ProGest; GENOMIC SOLUTIONS, Ann Arbor, MI). Peptides were 
separated by a nanoflow liquid-chromatography (LC) system on a 
reverse-phase column (C18 PepMap100, 3 μm, 100 Å, 25 cm; Di-
onex) and subjected to tandem mass spectrometry (MS/MS) analy-
sis (LTQ-Orbitrap XL, Thermo Fisher Scientific). The spectra were 
matched against the human database (UniProtKB/Swiss-Prot Re-
lease 14.6, 20,333 protein entries). Protein hits with identification 
probability > 99.0% and at least two unique peptides with identifi-
cation probability > 95% were selected using Scaffold software 
(version 2.0; Proteome Software, Portland, OR) and considered for 
further work. Mass spectrometry was performed by Xiaoke Yin 
(King’s College London).
Cytoplasmic and nuclear fractionations
Plated cells were washed twice with PBS and harvested by scraping 
cells in an appropriate volume of nuclear fractionation buffer 
(250 mM sucrose, 20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM 
MgCl2, 1 mM EDTA, 1 mM dithiothreitol, and protease inhibitor 
cocktail). The cells were collected and incubated on ice for 10 min; 
this was followed by a centrifugation at 845 × g for 10 min in a 4°C 
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were 5′GUCAUUCCAGCAGUCAUCUUU3′ and 5′GCUCCUCCAA-
GUAGCAAUAUU3′, respectively. Knockdown efficiency was ana-
lyzed using 10–20 μg of cell extract by Western blotting.
Immunofluorescence microscopy
Cells were fixed for 5 min in 3.7% paraformaldehyde (PFA) (Sigma-
Aldrich) followed by 2 min permeabilization with 0.5% NP-40 (EMD 
Millipore). The coverslips were incubated with blocking solution (1% 
bovine serum albumin) for 1 h at RT. Primary antibodies used for 
immune staining were diluted in blocking solution and applied to 
the coverslips for 1 h at RT; this was followed by three short rinses in 
PBS. Primary antibodies were as follows: anti-Matr3C (ab84422; 
Abcam), anti-Matr3N (ab51081; Abcam), and mouse anti-S6K used 
to detected Hedls (sc-8418; Santa Cruz) at 1:200; rabbit anti-Rck/
p54 (A300-461A; Bethyl Laboratories, Montgomery, TX) and mouse 
anti-PABP-1 (10E10, sc-32318; Santa Cruz) at 1:200. Next the cover-
slips were incubated with secondary antibodies, diluted 1:1000 in 
blocking buffer, and conjugated to Alexa Fluor 405, 488, or 546 
(Invitrogen, Carlsbad, CA) for 1 h at RT. The coverslips were next 
stained with 4′,6-diamidino-2-phenylindole and rinsed with PBS be-
fore being mounted onto slides using Mowiol mounting media. Im-
ages were acquired at RT using a using an Olympus IX81 wide-field 
microscope with a 40× air objective lens attached to a Hamamatsu 
Orca-R2 cooled CCD camera. Pearson’s colocalization coefficients 
were determined using the Coloc2 plug-in in imageJ.
ACKNOWLEDGMENTS
We thank the British Heart Foundation and Medical Research Coun-
cil for funding this work.
REFERENCES
Chang W, Worman HJ, Gundersen GG (2015). Accessorizing and anchoring 
the LINC complex for multifunctionality. J Cell Biol 208, 11–22.
Chen M, Manley JL (2009). Mechanisms of alternative splicing regulation: 
insights from molecular and genomics approaches. Nat Rev Mol Cell 
Biol 10, 741–754.
Chu CY, Rana TM (2006). Translation repression in human cells by mi-
croRNA-induced gene silencing requires RCK/p54. PLoS Biol 4, e210.
Coelho MB, Attig J, Bellora N, Konig J, Hallegger M, Kayikci M, Eyras E, Ule 
J, Smith CW (2015). Nuclear matrix protein Matrin3 regulates alternative 
splicing and forms overlapping regulatory networks with PTB. EMBO J 
34, 653–668.
Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, Burke B, Stahl PD, Hodzic 
D (2006). Coupling of the nucleus and cytoplasm: role of the LINC 
complex. J Cell Biol 172, 41–53.
Depreux FF, Puckelwartz MJ, Augustynowicz A, Wolfgeher D, Labno 
CM, Pierre-Louis D, Cicka D, Kron SJ, Holaska J, McNally EM (2015). 
Disruption of the lamin A and matrin-3 interaction by myopathic LMNA 
mutations. Hum Mol Genet 24, 4284–4295.
Doench JG, Petersen CP, Sharp PA (2003). siRNAs can function as miRNAs. 
Genes Dev 17, 438–442.
Emili A, Shales M, McCracken S, Xie W, Tucker PW, Kobayashi R, Blencowe BJ, 
Ingles CJ (2002). Splicing and transcription-associated proteins PSF and 
p54nrb/nonO bind to the RNA polymerase II CTD. RNA 8, 1102–1111.
Fuller-Pace FV, Ali S (2008). The DEAD box RNA helicases p68 (Ddx5) and 
p72 (Ddx17): novel transcriptional co-regulators. Biochem Soc Trans 36, 
609–612.
Gallego-Iradi MC, Clare AM, Brown HH, Janus C, Lewis J, Borchelt DR 
(2015). Subcellular localization of Matrin 3 containing mutations 
associated with ALS and distal myopathy. PLoS One 10, e0142144.
Hock J, Weinmann L, Ender C, Rudel S, Kremmer E, Raabe M, Urlaub H, 
Meister G (2007). Proteomic and functional analysis of Argonaute-
containing mRNA-protein complexes in human cells. EMBO Rep 8, 
1052–1060.
Holt I, Duong NT, Zhang Q, Lam LT, Sewry CA, Mamchaoui K, Shanahan 
CM, Morris GE (2016). Specific localization of nesprin-1-alpha2, the 
short isoform of nesprin-1 with a KASH domain, in developing, fetal and 
regenerating muscle, using a new monoclonal antibody. BMC Cell Biol 
17, 26.
Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R (2016). 
ATPase-modulated stress granules contain a diverse proteome and 
substructure. Cell 164, 487–498.
Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, 
Abramzon Y, Marangi G, Winborn BJ, et al. (2014). Mutations in the 
Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 
17, 664–666.
Johnston M, Geoffroy MC, Sobala A, Hay R, Hutvagner G (2010). HSP90 
protein stabilizes unloaded argonaute complexes and microscopic P-
bodies in human cells. Mol Biol Cell 21, 1462–1469.
Kobayashi Y, Katanosaka Y, Iwata Y, Matsuoka M, Shigekawa M, Wakabayashi 
S (2006). Identification and characterization of GSRP-56, a novel Golgi-lo-
calized spectrin repeat-containing protein. Exp Cell Res 312, 3152–3164.
Li YR, King OD, Shorter J, Gitler AD (2013). Stress granules as crucibles of 
ALS pathogenesis. J Cell Biol 201, 361–372.
Lytle JR, Yario TA, Steitz JA (2007). Target mRNAs are repressed as ef-
ficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc 
Natl Acad Sci USA 104, 9667–9672.
Ma H, Siegel AJ, Berezney R (1999). Association of chromosome territories 
with the nuclear matrix. Disruption of human chromosome territories 
correlates with the release of a subset of nuclear matrix proteins. J Cell 
Biol 146, 531–542.
Mellad JA, Warren DT, Shanahan CM (2011). Nesprins LINC the nucleus and 
cytoskeleton. Curr Opin Cell Biol 23, 47–54.
Nakayasu H, Berezney R (1991). Nuclear matrins: identification of the major 
nuclear matrix proteins. Proc Natl Acad Sci USA 88, 10312–10316.
Rajgor D, Mellad JA, Autore F, Zhang Q, Shanahan CM (2012). Multiple 
novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific 
intracellular scaffolds. PLoS One 7, e40098.
Rajgor D, Mellad JA, Soong D, Rattner JB, Fritzler MJ, Shanahan CM (2014). 
Mammalian microtubule P-body dynamics are mediated by nesprin-1. 
J Cell Biol 205, 457–475.
Rajgor D, Shanahan CM (2013). Nesprins: from the nuclear envelope and 
beyond. Expert Rev Mol Med 15, e5.
Razafsky D, Wirtz D, Hodzic D (2014). Nuclear envelope in nuclear position-
ing and cell migration. Adv Exp Med Biol 773, 471–490.
Roux KJ, Crisp ML, Liu Q, Kim D, Kozlov S, Stewart CL, Burke B (2009). 
Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-
mediated cell polarization. Proc Natl Acad Sci USA 106, 2194–2199.
Salton M, Elkon R, Borodina T, Davydov A, Yaspo ML, Halperin E, Shiloh Y 
(2011). Matrin 3 binds and stabilizes mRNA. PLoS One 6, e23882.
Salton M, Lerenthal Y, Wang SY, Chen DJ, Shiloh Y (2010). Involvement of 
matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9, 
1568–1576.
Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, 
Elbracht M, Stendel C, Tournev I, Mihailova V, et al. (2009). Autosomal-
dominant distal myopathy associated with a recurrent missense muta-
tion in the gene encoding the nuclear matrix protein, matrin 3. Am J 
Hum Genet 84, 511–518.
Warren DT, Tajsic T, Mellad JA, Searles R, Zhang Q, Shanahan CM (2010). 
Novel nuclear nesprin-2 variants tether active extracellular signal-
regulated MAPK1 and MAPK2 at promyelocytic leukemia protein 
nuclear bodies and act to regulate smooth muscle cell proliferation. 
J Biol Chem 285, 1311–1320.
Wilhelmsen K, Litjens SH, Kuikman I, Tshimbalanga N, Janssen H, van den 
Bout I, Raymond K, Sonnenberg A (2005). Nesprin-3, a novel outer 
nuclear membrane protein, associates with the cytoskeletal linker 
protein plectin. J Cell Biol 171, 799–810.
Zeitz MJ, Malyavantham KS, Seifert B, Berezney R (2009). Matrin 3: 
chromosomal distribution and protein interactions. J Cell Biochem 
108, 125–133.
Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, Ragnauth 
CD, Yi Q, Mellad JA, Warren DT, et al. (2007). Nesprin-1 and -2 are 
involved in the pathogenesis of Emery Dreifuss muscular dystrophy 
and are critical for nuclear envelope integrity. Hum Mol Genet 16, 
2816–2833.
Zhang Q, Ragnauth C, Greener MJ, Shanahan CM, Roberts RG (2002). The 
nesprins are giant actin-binding proteins, orthologous to Drosophila 
melanogaster muscle protein MSP-300. Genomics 80, 473–481.
Zhang Q, Skepper JN, Yang F, Davies JD, Hegyi L, Roberts RG, Weissberg 
PL, Ellis JA, Shanahan CM (2001). Nesprins: a novel family of spectrin-
repeat-containing proteins that localize to the nuclear membrane in 
multiple tissues. J Cell Sci 114, 4485–4498.
Zhang Z, Carmichael GG (2001). The fate of dsRNA in the nucleus: a 
p54(nrb)-containing complex mediates the nuclear retention of 
promiscuously A-to-I edited RNAs. Cell 106, 465–475.
